(Sharecast News) - 4basebio reported strong progress for the year ended 31 December on Tuesday, with revenue doubling from DNA sales to £0.93m and key operational milestones achieved.
The AIM-traded, Cambridge-based synthetic DNA specialist secured a GMP manufacturing licence from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and supplied...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE